```html
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>Psoriasis – Primary Care Quick Algorithm</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <style>
    :root {
      --bg-page: #f4f6fb;
      --bg-card: #ffffff;
      --border-card: #e0e4f0;
      --accent: #3b6bc6;
      --accent-soft: #e4ecff;
      --text-main: #203047;
      --text-muted: #6c7a96;
      --danger: #d62839;
      --danger-soft: #ffe5e8;
      --positive: #2f984f;
      --positive-soft: #e4f7ea;
      --chip-bg: #eef1fb;
      --shadow-soft: 0 8px 20px rgba(23, 42, 96, 0.08);
      --radius-lg: 18px;
      --radius-pill: 999px;
    }

    * {
      box-sizing: border-box;
    }

    body {
      margin: 0;
      font-family: system-ui, -apple-system, BlinkMacSystemFont, "Segoe UI",
        Roboto, sans-serif;
      background: radial-gradient(circle at top left, #ffffff 0, #f4f6fb 50%);
      color: var(--text-main);
      line-height: 1.5;
    }

    .page {
      max-width: 1200px;
      margin: 0 auto;
      padding: 24px 16px 40px;
    }

    header {
      display: flex;
      flex-direction: column;
      gap: 12px;
      margin-bottom: 24px;
    }

    header h1 {
      margin: 0;
      font-size: 1.9rem;
      letter-spacing: 0.03em;
      text-transform: uppercase;
      color: var(--accent);
    }

    header p {
      margin: 0;
      color: var(--text-muted);
      max-width: 720px;
    }

    .pill-row {
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
    }

    .pill {
      padding: 6px 12px;
      border-radius: var(--radius-pill);
      font-size: 0.78rem;
      text-transform: uppercase;
      letter-spacing: 0.06em;
      border: 1px solid rgba(59, 107, 198, 0.18);
      background: #ffffff;
      color: var(--accent);
    }

    .layout {
      display: grid;
      grid-template-columns: minmax(0, 2.2fr) minmax(260px, 1.3fr);
      gap: 18px;
      align-items: flex-start;
    }

    @media (max-width: 900px) {
      .layout {
        grid-template-columns: minmax(0, 1fr);
      }
    }

    .card {
      background: var(--bg-card);
      border-radius: var(--radius-lg);
      border: 1px solid var(--border-card);
      box-shadow: var(--shadow-soft);
      padding: 16px 18px 18px;
    }

    .card h2 {
      margin: 0 0 8px;
      font-size: 1.05rem;
      display: flex;
      align-items: center;
      gap: 8px;
    }

    .card h3 {
      margin: 14px 0 4px;
      font-size: 0.95rem;
    }

    .subnote {
      font-size: 0.8rem;
      color: var(--text-muted);
    }

    .tag {
      font-size: 0.7rem;
      text-transform: uppercase;
      letter-spacing: 0.06em;
      padding: 3px 8px;
      border-radius: var(--radius-pill);
    }

    .tag-danger {
      background: var(--danger-soft);
      color: var(--danger);
    }

    .tag-positive {
      background: var(--positive-soft);
      color: var(--positive);
    }

    .tag-neutral {
      background: var(--chip-bg);
      color: var(--text-muted);
    }

    ul {
      padding-left: 18px;
      margin: 4px 0 4px;
      font-size: 0.9rem;
    }

    li + li {
      margin-top: 2px;
    }

    .legend {
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
      margin-bottom: 10px;
      font-size: 0.8rem;
    }

    .legend span {
      display: inline-flex;
      align-items: center;
      gap: 6px;
    }

    .dot {
      width: 12px;
      height: 12px;
      border-radius: 50%;
    }

    .dot.danger {
      background: var(--danger);
    }

    .dot.positive {
      background: var(--positive);
    }

    .dot.neutral {
      background: var(--accent);
    }

    .red-flag {
      border-left: 4px solid var(--danger);
      background: linear-gradient(
        135deg,
        var(--danger-soft),
        #fff7f7
      );
      margin-bottom: 14px;
    }

    .red-flag h2 {
      color: var(--danger);
    }

    .section-grid {
      display: grid;
      grid-template-columns: minmax(0, 1fr);
      gap: 12px;
    }

    .flow-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
      gap: 12px;
      margin-top: 4px;
    }

    .flow-step {
      border-left: 3px solid var(--accent);
      padding-left: 10px;
      margin-top: 6px;
    }

    .flow-step h3 {
      display: flex;
      justify-content: space-between;
      align-items: baseline;
    }

    .badge {
      font-size: 0.7rem;
      padding: 2px 6px;
      border-radius: var(--radius-pill);
      background: var(--accent-soft);
      color: var(--accent);
      text-transform: uppercase;
      letter-spacing: 0.05em;
    }

    .mini {
      font-size: 0.8rem;
      color: var(--text-muted);
      margin-top: 6px;
    }

    .btn-toggle {
      border: none;
      background: transparent;
      color: var(--accent);
      font-size: 0.8rem;
      cursor: pointer;
      padding: 0;
      display: inline-flex;
      align-items: center;
      gap: 4px;
    }

    .btn-toggle svg {
      width: 13px;
      height: 13px;
      transition: transform 0.2s ease;
    }

    .section.collapsed .section-body {
      display: none;
    }

    .section.collapsed .btn-toggle svg {
      transform: rotate(-90deg);
    }

    .section-header {
      display: flex;
      justify-content: space-between;
      align-items: center;
      gap: 10px;
      margin-bottom: 4px;
    }

    .section-header h2 {
      font-size: 1rem;
    }

    .chips {
      display: flex;
      flex-wrap: wrap;
      gap: 6px;
      margin-top: 4px;
    }

    .chip {
      padding: 4px 8px;
      font-size: 0.75rem;
      border-radius: var(--radius-pill);
      background: var(--chip-bg);
      color: var(--text-muted);
    }

    .chip.danger {
      background: var(--danger-soft);
      color: var(--danger);
    }

    .chip.positive {
      background: var(--positive-soft);
      color: var(--positive);
    }

    .right-column .card + .card {
      margin-top: 12px;
    }
  </style>
</head>
<body>
  <div class="page">
    <header>
      <div class="pill-row">
        <span class="pill">Primary Care • Adult</span>
        <span class="pill">Psoriasis Quick Algorithm</span>
      </div>
      <h1>Psoriasis: One-Page Decision Aid</h1>
      <p>
        Fast reference for assessment and management of adult psoriasis in primary
        care: when to treat, what to use, and when to refer.
      </p>
    </header>

    <div class="layout">
      <!-- LEFT COLUMN: MAIN FLOWS -->
      <div>
        <!-- Legend -->
        <div class="card">
          <div class="legend">
            <span><span class="dot danger"></span> Red flags / concerning features</span>
            <span><span class="dot positive"></span> Positive / desired action</span>
            <span><span class="dot neutral"></span> Neutral clinical information</span>
          </div>
        </div>

        <!-- Red flags -->
        <section class="card red-flag section" data-section>
          <div class="section-header">
            <h2>Immediate Red Flags</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <p class="subnote">
              Any of the following in a person with psoriasis ➜
              <strong style="color: var(--danger);">same-day specialist / emergency care</strong>.
            </p>
            <ul>
              <li><strong>Generalised pustular psoriasis</strong> (rapid erythema, widespread sterile pustules, systemic illness).</li>
              <li><strong>Erythrodermic psoriasis</strong> (&gt;90% BSA, hot/red skin, fever, malaise, oedema, haemodynamic instability).</li>
              <li>Severe systemic symptoms: high fever, tachycardia, weight loss, hypothermia or dehydration.</li>
              <li>Severe or atypical psoriasis as possible
                <span style="color: var(--danger);">HIV indicator condition</span>.
              </li>
            </ul>
          </div>
        </section>

        <!-- Assessment & baseline management -->
        <section class="card section" data-section>
          <div class="section-header">
            <h2>1. Confirm Diagnosis & Assess Severity</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <p class="subnote">
              Identify type(s) of psoriasis and impact before choosing treatment.
            </p>
            <div class="chips">
              <div class="chip">Chronic plaque</div>
              <div class="chip">Scalp</div>
              <div class="chip">Facial</div>
              <div class="chip">Flexural / genital</div>
              <div class="chip">Guttate</div>
              <div class="chip">Nail</div>
              <div class="chip danger">Pustular</div>
              <div class="chip danger">Erythrodermic</div>
            </div>

            <h3>History</h3>
            <ul>
              <li>Onset, course (relapsing/remitting), distribution, symptoms (itch, pain, bleeding, scaling).</li>
              <li>Triggers: infection, trauma (Koebner), drugs (lithium, antimalarials, β-blockers, NSAIDs, ACE-i), stress, alcohol, smoking.</li>
              <li>Systemic symptoms: fever, malaise, weight loss.</li>
              <li>Joint symptoms: stiffness, pain, swelling, dactylitis, enthesitis.</li>
              <li>Assess with PEST; score
                <span class="tag tag-danger">≥3 ➜ rheumatology referral</span>.
              </li>
              <li>Psychological impact, DLQI, anxiety/depression, effect on work/relationships.</li>
              <li>Comorbidities: obesity, metabolic syndrome, IBD, CVD, VTE risk.</li>
            </ul>

            <h3>Examination</h3>
            <ul>
              <li>Full skin exam: distribution (extensors, scalp, flexures, genital, trunk), lesion type, scale, colour, Auspitz sign.</li>
              <li>Assess BSA (Rule of Nines). Extensive disease usually
                <span class="tag tag-danger">&gt;10% BSA</span>.
              </li>
              <li>Check nails: pitting, onycholysis, “oil drop”, subungual hyperkeratosis.</li>
              <li>Joints: swelling, tenderness, spinal and entheseal pain.</li>
            </ul>
          </div>
        </section>

        <section class="card section" data-section>
          <div class="section-header">
            <h2>2. First-Line for All Patients</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <div class="flow-step">
              <h3>
                General Measures
                <span class="badge">Foundations</span>
              </h3>
              <ul>
                <li><span class="tag tag-positive">Daily emollients</span> for dryness, scale and itch; improve penetration of other topicals.</li>
                <li>Lifestyle: weight loss if overweight, stop smoking, limit alcohol.</li>
                <li>Address stress, anxiety, depression; signpost to support groups.</li>
                <li>Reassure: psoriasis is
                  <span class="tag tag-positive">not infectious</span>.
                </li>
              </ul>
            </div>

            <div class="flow-step">
              <h3>
                Education & Monitoring
                <span class="badge">Ongoing</span>
              </h3>
              <ul>
                <li>Explain aim is symptom control; complete clearance may not be achievable.</li>
                <li>Demonstrate application technique; discuss cosmetic acceptability.</li>
                <li>Review at ~4 weeks, then as needed (and at least yearly if using potent steroids).</li>
                <li>Advise to seek urgent review if new unexplained joint pain or swelling.</li>
              </ul>
              <p class="mini">
                Check CVD risk at baseline and at least every 5 years, especially with severe disease.
              </p>
            </div>
          </div>
        </section>

        <!-- Site-specific algorithms -->
        <section class="card section" data-section>
          <div class="section-header">
            <h2>3. Site-Specific Treatment Pathways</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <div class="flow-grid">
              <!-- Chronic plaque trunk/limbs -->
              <div class="flow-step">
                <h3>Chronic Plaque – Trunk &amp; Limbs</h3>
                <ol style="margin-left: 16px; font-size: 0.9rem;">
                  <li>
                    <strong>Initial (up to 4 weeks)</strong><br />
                    <span class="tag tag-positive">Potent steroid OD</span> +
                    <span class="tag tag-positive">Vit D analogue OD</span> (different times).
                  </li>
                  <li>
                    <strong>If response adequate</strong><br />
                    Continue until clear/nearly clear.<br />
                    Steroid max
                    <span class="tag tag-danger">8 weeks per site</span>, then 4-week break
                    (continue Vit D).
                  </li>
                  <li>
                    <strong>If inadequate</strong><br />
                    ➜ Stop steroid, use Vit D analogue
                    <span class="tag tag-positive">BD for 8–12 weeks</span>.
                  </li>
                  <li>
                    <strong>If still inadequate</strong><br />
                    ➜
                    <span class="tag tag-positive">Potent steroid BD for 4 weeks</span>
                    <em>or</em> coal tar prep
                    <em>or</em> calcipotriol + betamethasone combo up to 4 weeks (once daily).
                  </li>
                  <li>
                    <strong>Refractory / severe</strong><br />
                    Consider short-contact dithranol (usually specialist-guided).
                  </li>
                </ol>
              </div>

              <!-- Scalp -->
              <div class="flow-step">
                <h3>Scalp Psoriasis</h3>
                <ol style="margin-left: 16px; font-size: 0.9rem;">
                  <li>
                    <strong>First line (4 weeks)</strong><br />
                    <span class="tag tag-positive">Potent steroid OD</span>.
                  </li>
                  <li>
                    <strong>If inadequate</strong><br />
                    Change formulation (e.g. shampoo/mousse) and add scale removal
                    (salicylic acid, oils, emollients) applied <em>before</em> steroid.
                  </li>
                  <li>
                    <strong>Still inadequate after a further 4 weeks</strong><br />
                    ➜ Calcipotriol + betamethasone combo up to 4 weeks.
                  </li>
                  <li>
                    <strong>Still inadequate</strong><br />
                    ➜ Very potent steroid BD for 2 weeks
                    <em>or</em> coal tar preparation
                    <em>or</em> refer.
                  </li>
                  <li>
                    <strong>If cannot use steroids (mild–moderate)</strong><br />
                    Vit D analogue alone up to 8 weeks → if inadequate, coal tar or refer.
                  </li>
                </ol>
              </div>

              <!-- Facial/flexural/genital -->
              <div class="flow-step">
                <h3>Facial, Flexural &amp; Genital</h3>
                <ul>
                  <li>
                    <strong>First line</strong>:
                    <span class="tag tag-positive">Mild or moderate steroid</span>,
                    limited to
                    <span class="tag tag-danger">1–2 weeks/month</span>
                    because of atrophy risk.
                  </li>
                  <li>
                    <strong>If inadequate or steroid risk high</strong>:
                    <span class="tag tag-positive">Topical calcineurin inhibitor</span>
                    (tacrolimus/pimecrolimus) for up to 4 weeks –
                    typically specialist-initiated.
                  </li>
                </ul>
              </div>

              <!-- Guttate -->
              <div class="flow-step">
                <h3>Guttate Psoriasis</h3>
                <ul>
                  <li>Often self-limiting (resolves within 3–4 months).</li>
                  <li>Treat with emollients and topical therapies as for trunk/limbs.</li>
                  <li>
                    <span class="tag tag-danger">Refer</span> if severe, persistent,
                    diagnostic uncertainty, or recurrent episodes.
                  </li>
                </ul>
              </div>

              <!-- Nail -->
              <div class="flow-step">
                <h3>Nail Psoriasis</h3>
                <ul>
                  <li>Consider high-potency steroid or Vit D analogue to nail folds/plate.</li>
                  <li>
                    <span class="tag tag-danger">Refer</span> if functionally limiting,
                    severe cosmetic impact, or associated with suspected psoriatic arthritis.
                  </li>
                </ul>
              </div>
            </div>
          </div>
        </section>

        <!-- Referral & systemic / phototherapy -->
        <section class="card section" data-section>
          <div class="section-header">
            <h2>4. When to Refer & Systemic Options</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <div class="flow-grid">
              <div class="flow-step">
                <h3>Indications for Dermatology Referral</h3>
                <ul>
                  <li class="chip danger">Pustular or erythrodermic psoriasis (same day)</li>
                  <li>Failure of adequate topical therapy despite good adherence.</li>
                  <li>Extensive disease
                    <span class="tag tag-danger">&gt;10% BSA</span> or high DLQI / severe psychological impact.
                  </li>
                  <li>Diagnostic difficulty or atypical presentation.</li>
                  <li>Need for phototherapy or systemic therapy.</li>
                </ul>
                <h3>Rheumatology Referral</h3>
                <ul>
                  <li>PEST score
                    <span class="tag tag-danger">≥3</span> or suggestive joint symptoms.</li>
                </ul>
              </div>
              <div class="flow-step">
                <h3>Specialist-Led Therapies</h3>
                <ul>
                  <li><strong>Phototherapy</strong>: NB-UVB for plaque/guttate; PUVA for selected cases
                    (e.g. palmoplantar, resistant plaques).</li>
                  <li><strong>Systemic non-biologics</strong>: methotrexate or ciclosporin
                    (rapid or short-term control; palmoplantar pustulosis; considering conception).
                  </li>
                  <li>Acitretin if methotrexate/ciclosporin not suitable or for pustular forms.</li>
                  <li>Other oral agents (e.g. apremilast, dimethyl fumarate, selected JAK/TYK2 inhibitors) for moderate–severe plaque psoriasis.</li>
                  <li><strong>Biologics</strong> (IL / TNF-α inhibitors) – specialist initiation and monitoring only.</li>
                </ul>
              </div>
            </div>
          </div>
        </section>
      </div>

      <!-- RIGHT COLUMN: COMPACT CHECKLISTS -->
      <div class="right-column">
        <div class="card section" data-section>
          <div class="section-header">
            <h2>5. Monitoring & Follow-Up</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <ul>
              <li>
                <span class="tag tag-positive">4-week review</span> after starting or changing topical therapy:
                response, adherence, tolerability, impact on life.
              </li>
              <li>
                At least
                <span class="tag tag-positive">annual review</span> if using multiple intermittent/short
                courses of potent steroids – check for atrophy, striae and optimise regimen.
              </li>
              <li>
                Assess CVD risk at diagnosis in severe psoriasis and at least every 5 years
                (BP, lipids, diabetes risk).
              </li>
              <li>Advise on VTE risk and preventive measures in severe disease.</li>
              <li>Annual assessment for psoriatic arthritis symptoms.</li>
            </ul>
          </div>
        </div>

        <div class="card section" data-section>
          <div class="section-header">
            <h2>6. Quick Drug Safety Reminders</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <ul>
              <li>
                Avoid continuous long-term use of potent / very potent topical steroids:
                risk of irreversible atrophy and unstable psoriasis.
              </li>
              <li>
                Do <strong>not</strong> use potent steroid courses
                <span class="tag tag-danger">&gt;8 weeks at one site</span>;
                very potent steroids for
                <span class="tag tag-danger">&gt;4 weeks</span>.
              </li>
              <li>Beware rebound and possible generalised pustular/erythrodermic flare after abrupt withdrawal of systemic or potent topical steroids.</li>
              <li>In phototherapy/PUVA, cumulative dose increases risk of dysplastic/neoplastic lesions (esp. SCC) – specialist monitoring required.</li>
              <li>Systemic therapies (methotrexate, ciclosporin, JAK/TYK2 inhibitors, biologics) require strict lab and safety monitoring under specialist care.</li>
            </ul>
          </div>
        </div>

        <div class="card section" data-section>
          <div class="section-header">
            <h2>7. Patient Resources</h2>
            <button class="btn-toggle" type="button">
              <svg viewBox="0 0 16 16">
                <path d="M4 6l4 4 4-4" fill="none" stroke="currentColor" stroke-width="1.6" />
              </svg>
              Hide/Show
            </button>
          </div>
          <div class="section-body">
            <ul>
              <li>Psoriasis and Psoriatic Arthritis Alliance (PAPAA) – education, lifestyle, and psychological support.</li>
              <li>Psoriasis Association – patient information and community support.</li>
              <li>British Association of Dermatologists and NHS online leaflets for psoriasis and topical treatments.</li>
            </ul>
          </div>
        </div>
      </div>
    </div>
  </div>

  <script>
    // Simple collapse/expand for sections
    document.querySelectorAll("[data-section]").forEach((section) => {
      const btn = section.querySelector(".btn-toggle");
      if (!btn) return;
      btn.addEventListener("click", () => {
        section.classList.toggle("collapsed");
      });
    });
  </script>
</body>
</html>
```
